Quarterly report pursuant to Section 13 or 15(d)

Subsequent Events (Details)

v3.7.0.1
Subsequent Events (Details) - Subsequent Event
Aug. 14, 2017
USD ($)
$ / shares
shares
Common Stock Purchase Agreement  
Business Combination, Consideration Transferred [Abstract]  
Sale of stock, maximum consideration to be received on transaction | $ $ 16,000,000.0
Sale of stock, price per share (in dollars per share) | $ / shares $ 3.00
Sale of stock, purchase agreement term 24 months
Sale of stock, number of shares required to be purchased per day by counterparty (in shares) 33,333
Sale of stock, minimum closing trade price per share required by counterparty in order to purchase daily amount (in dollars per share) | $ / shares $ 3.00
Sale of stock, maximum number of additional shares required to be purchased per day upon mutual agreement 2,000,000
Sale of stock, maximum number of shares issuable in transaction on purchase agreement date 3,938,213
Sale of stock, maximum percentage of ownership that can be sold 19.90%
Common Stock Purchase Agreement - Commitment Shares  
Business Combination, Consideration Transferred [Abstract]  
Sale of stock, number of shares issued in transaction (in shares) 320,000
Common Stock Purchase Agreement - Initial Purchase Price  
Business Combination, Consideration Transferred [Abstract]  
Sale of stock, number of shares issued in transaction (in shares) 1,000,000
vivoPharm  
Business Combination, Consideration Transferred [Abstract]  
Business combination, consideration transferred | $ $ 12,000,000
Business combination, cash paid | $ 1,200,000
Business combination, equity interests issued, value | $ $ 10,800,000
Business combination, weighted average share price, length of trailing period 20 days
Business combination, consideration transferred, percentage withheld in escrow 20.00%
Business combination, consideration transferred, escrow expiration period 12 months